Skip to main content

A Randomized Phase II Study Evaluating Pembrolizumab vs Topotecan in the Second-line Treatment of Patients with Small Cell Lung Cancer

Clinical Trial Grant
Duke Scholars

Awarded By

TESARO

Start Date

January 4, 2018

End Date

September 21, 2020
 

Awarded By

TESARO

Start Date

January 4, 2018

End Date

September 21, 2020